Article Information
History
- May 8, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Annelyn Torres-Reveron1,5 (annelyn.torresreveron{at}utrgv.edu),
- Leslie L Rivera-Lopez2 (leslie.riveralopez{at}utrgv.edu),
- Idhaliz Flores3 (iflores{at}psm.edu) and
- Caroline B. Appleyard4 (cappleyard{at}psm.edu)
- 1 University of Texas Rio Grande Valley School of Medicine;
- 2 University of Texas Rio Grande Valley;
- 3 Ponce Health Sciences University/Ponce Research Institute;
- 4 Ponce Health Sciences University and Ponce Research Institute
- ↵* Corresponding author; email: annelyn.torresreveron{at}utrgv.edu
Posted May 08, 2018.
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.
